TP53 and Burkitt lymphoma: Overall, our findings provide evidence that the simultaneous treatment of Ib and dEZH2 in Burkitt’s lymphoma induces apoptosis through the miR29b-mediated TP53 upregulated pathway, thereby exhibiting potent anti-tumor effects (Figure 7).